ZT002

DRUG2 trials

Sponsors

QL Biopharmaceutical Australia Pty Ltd, Beijing QL Biopharmaceutical Co.,Ltd

Conditions

Type 2 Diabetes Mellitus

Phase 1

A Study of ZT002 in Healthy Participants

CompletedNCT05491421

QL Biopharmaceutical Australia Pty LtdType 2 Diabetes Mellitus

Start: 2022-09-02End: 2023-04-28Updated: 2026-01-16

A SAD Study of ZT002 Injection in Healthy Participants

CompletedNCT06423872

Beijing QL Biopharmaceutical Co.,LtdType 2 Diabetes Mellitus

Start: 2023-06-19End: 2023-12-08Updated: 2024-05-21